Share Twitter LinkedIn Facebook Email John Strickler, M.D. Assistant Professor Of Medicine At Duke Cancer Institute, Discusses KEYNOTE-181 Esophageal Cancer Study. At The 2019 Gastrointestinal Cancers Symposium In San Francisco, CA On Jan 17, 2019. http://obroncology.com
FDA Approves TEVIMBRA for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma Gastrointestinal 3 Mins Read
Why isn’t CAR-T Therapy Revolutionizing the Fight Against GI Cancers? 17 Trial Insights from ASCO GI 2025 Gastrointestinal 4 Mins Read
Nivolumab + Ipilimumab Shows Improved Outcomes in MSI-H/dMMR mCRC CheckMate-8HW Trial ASCO GI 2 Mins Read